Skip to content

Clinical trials

Kidney Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Country / region: China Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20072
20081
20091
20132
20163
20172
20182
20191
20214
20225
20234
202410
202514
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting31
Unknown status12
Completed9
Not yet recruiting5
Active, not recruiting3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital6
Peking University First Hospital5
Jinling Hospital, China4
Pfizer4
Fuda Cancer Hospital, Guangzhou3
Fudan University3
Sun Yat-sen University3
Shao Pengfei2
Tianjin Medical University Second Hospital2
Beijing Biotech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms62
Carcinoma, Renal Cell28
Lung Neoplasms7
Melanoma7
Neoplasms6
Breast Neoplasms5
Carcinoma5
Colorectal Neoplasms5
Prostatic Neoplasms5
Esophageal Neoplasms4

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.